Brief: Karyopharm Announces Clinical Trial Collaboration With Bristol Myers Squibb

Karyopharm Therapeutics

30/10/2023 12:15

Oct 30 (Reuters) - Bristol-Myers Squibb Co  BMY.N :
    * KARYOPHARM ANNOUNCES CLINICAL TRIAL COLLABORATION WITH
BRISTOL
MYERS SQUIBB TO EVALUATE NOVEL CELMOD™ AGENT CC- 92480
MEZIGDOMIDE IN COMBINATION WITH SELINEXOR IN PATIENTS WITH
RELAPSED/REFRACTORY MULTIPLE MYELOMA
    * KARYOPHARM THERAPEUTICS INC-  PHASE 1B/2 TRIAL TO
INVESTIGATE
MEZIGDOMIDE IN COMBINATION WITH SELINEXOR EXPECTED TO BE
INITIATED 1H 2024

Source text for Eikon:  ID:nPn3qgfhfa 
Further company coverage:  BMY.N 

 ((Reuters.Briefs@thomsonreuters.com;))